Speaker
Description
About Genialis
Genialis is the RNA biomarker company. They develop and validate clinically actionable biomarkers to help pharmaceutical and diagnostic partners predict patient responses and guide treatment decisions in the field of oncology. Genialis does that by using biology-informed machine learning that models dozens of biological processes from gene expression of cancer patients’ tumors. Their algorithms are trained on one of the world’s most ethno-geographically diverse cancer data sets, with the mission of creating a world where healthcare delivers the best possible outcomes for patients, their families, and their communities.
About Dr. Luka Ausec
Dr. Luka Ausec is the Chief Discovery Officer at Genialis. He holds a Ph.D. in molecular biology and biotechnology from the University of Ljubljana. With a strong background in both biology and computational disciplines, Luka is skilled at innovating solutions where these fields meet. At Genialis, he directs internal R&D and external partner projects, all with the shared goal of transforming medicine through data.
